Philip P Stashenko, Age 7717 Bliss Rd, Newport, RI 02840
Philip Stashenko Phones & Addresses
Newport, RI
Millis, MA
Providence, RI
Ponte Vedra Beach, FL
Cambridge, MA
Medfield, MA
Boston, MA
Norfolk, MA
Saint Johns, FL
Newtonville, MA
Mentions for Philip P Stashenko
Publications & IP owners
Us Patents
Human Osteoclast-Specific And -Related Dna Sequences
US Patent:
6403304, Jun 11, 2002
Filed:
Jul 19, 1996
Appl. No.:
08/684932
Inventors:
Philip Stashenko - Norfolk MA
Yi-Ping Li - Boston MA
Anne L. Wucherpfennig - Brookline MA
Yi-Ping Li - Boston MA
Anne L. Wucherpfennig - Brookline MA
Assignee:
Forsyth Dental Infirmary for Children - Boston MA
International Classification:
C07H 2104
US Classification:
435 6, 4352523, 4353201, 435 691, 536 231
Abstract:
The present invention relates to purified osteoclast-specific or -related DNA sequences and a method for identifying such sequences. DNA constructs capable of replicating osteoclast-specific or -related DNA and DNA constructs capable of directing expression in a host cell of osteoclast-specific or -related DNA are also described.
Characterization Of An Antibiotic Impregnated Delivery System As An Intracanal Medicament In Endodontic Therapy And Method
US Patent:
6712610, Mar 30, 2004
Filed:
Sep 26, 2001
Appl. No.:
09/963880
Inventors:
Mario Abdennour - Newton MA
Philip Stashenko - Medfield MA
Michele Scrime - Manalapan NJ
Jack Gilad - Chestnut Hill MA
Max Goodson - Cambridge MA
Philip Stashenko - Medfield MA
Michele Scrime - Manalapan NJ
Jack Gilad - Chestnut Hill MA
Max Goodson - Cambridge MA
Assignee:
Forsyth Dental Infirmary for Children - Boston MA
President and Fellow of Harvard College - Cambridge MA
President and Fellow of Harvard College - Cambridge MA
International Classification:
A61C 502
US Classification:
433 81, 433224
Abstract:
Endodontic fibers comprising a biocompatible polymer vehicle permeable to medicaments, or combinations of medicaments are described. Such fibers can be used, for example, in a method for the local delivery and sustained release of medicaments to periodontal or intracanal treatment sites. Endodontic fibers described include modified periodontal fibers and intracanal fibers.
Osteoclast Proton Pump Subunit
US Patent:
6777537, Aug 17, 2004
Filed:
Jul 18, 2000
Appl. No.:
09/618304
Inventors:
Philip Stashenko - Norfolk MA
Yi-Ping Li - Boston MA
Yi-Ping Li - Boston MA
Assignee:
Forsyth Dental Infirmary for Children - Boston MA
International Classification:
C07K 14435
US Classification:
530350
Abstract:
Novel gene encoding a human 116-kDa osteoclast proton pump subunit and the protein encoded thereby. Methods of treatment of bone mass disorders utilizing said gene, and antibodies that bind to the protein encoded by said gene.
Methods For Increasing Bone Density
US Patent:
7326733, Feb 5, 2008
Filed:
Jun 2, 2003
Appl. No.:
10/453273
Inventors:
Philip Stashenko - Medfield MA, US
Richard Battaglino - Boston MA, US
Richard Battaglino - Boston MA, US
Assignee:
The Forsyth Institute - Boston MA
International Classification:
A61K 31/135
US Classification:
514647
Abstract:
Methods and compounds for remodeling bone and treating osteopenic conditions are described. Methods and compounds for increasing bone mineral density by decreasing serotonin levels in osteoblasts are also described.
Characterization Of An Antibiotic Impregnated Delivery System As An Intracanal Medicament In Endodontic Therapy
US Patent:
7331787, Feb 19, 2008
Filed:
Mar 29, 2004
Appl. No.:
10/812638
Inventors:
Mario Abdennour - Newton MA, US
Philip Stashenko - Medfield MA, US
Michele Scrime - Manalapan NJ, US
Jack Gilad - Chestnut Hill MA, US
Max Goodson - Cambridge MA, US
Philip Stashenko - Medfield MA, US
Michele Scrime - Manalapan NJ, US
Jack Gilad - Chestnut Hill MA, US
Max Goodson - Cambridge MA, US
Assignee:
Novalar Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61C 5/02
US Classification:
433 81
Abstract:
Endodontic fibers comprising a biocompatible polymer vehicle permeable to medicaments, or combinations of medicaments are described. Such fibers can be used, for example, in a method for the local delivery and sustained release of medicaments to periodontal or intracanal treatment sites. Endodontic fibers described include modified periodontal fibers and intracanal fibers.
Characterization Of An Antibiotic Impregnated Delivery System As An Intracanal Medicament In Endodontic Therapy
US Patent:
7946849, May 24, 2011
Filed:
Dec 17, 2007
Appl. No.:
11/957936
Inventors:
Mario Abdennour - Newton MA, US
Philip Stashenko - Medfield MA, US
Michele Scrime - Manalapan NJ, US
Jack Gilad - Chestnut Hill MA, US
Max Goodson - Cambridge MA, US
Philip Stashenko - Medfield MA, US
Michele Scrime - Manalapan NJ, US
Jack Gilad - Chestnut Hill MA, US
Max Goodson - Cambridge MA, US
Assignee:
Forsyth Dental Infirmary for Children - Boston MA
International Classification:
A61C 5/02
US Classification:
433224, 433 81
Abstract:
Endodontic fibers including a biocompatible polymer vehicle permeable to medicaments, or combinations of medicaments, and method of using such endodontic fibers are described. Such fibers can be used, for example, in a method for the local delivery and sustained release of medicaments to intracanal treatment sites.
Method Of Inhibiting An Activity Of A Gene Product In A Bone Cell Encoded By A Nucleotide Sequence Comprising Seq Id No: 50
US Patent:
8158123, Apr 17, 2012
Filed:
Dec 11, 2003
Appl. No.:
10/734692
Inventors:
Philip Stashenko - Medfield MA, US
Yoshimura Okamatsu - Boston MA, US
Hajime Sasaki - Needham MA, US
Richard Battaglino - Boston MA, US
Ulrike Späte - Boston MA, US
Yoshimura Okamatsu - Boston MA, US
Hajime Sasaki - Needham MA, US
Richard Battaglino - Boston MA, US
Ulrike Späte - Boston MA, US
Assignee:
Forsyth Dental Infirmary for Children - Cambridge MA
International Classification:
A61K 39/395
US Classification:
4241301
Abstract:
The present invention features methods of treating a bone resorption disease or a bone generating disease, methods for prognosing and/or diagnosing a bone resorption disease or a bone generating disease, methods for identifying a compound that modulates bone resorption disease development or bone generating disease development, methods for determining the efficacy of a bone resorption disease therapy or a bone generating disease therapy, and oligonucleotide microarrays containing probes for genes involved in osteoclast development.
Antibacterial Compositions
US Patent:
8399220, Mar 19, 2013
Filed:
Apr 16, 2010
Appl. No.:
12/762234
Inventors:
Toshihisa Kawai - Brookline MA, US
Philip P. Stashenko - Medfield MA, US
Yoshiaka Hosokawa - Tokushima, JP
Kazuhisa Ohara - Hiroshima, JP
Philip P. Stashenko - Medfield MA, US
Yoshiaka Hosokawa - Tokushima, JP
Kazuhisa Ohara - Hiroshima, JP
Assignee:
Forsyth Dental Infirmary for Children - Cambridge MA
International Classification:
C12P 21/04
US Classification:
435 701, 435 711
Abstract:
The present invention relates to oral antibacterial compositions comprising trihydroxybenzoate derivatives, e. g. , useful for the treatment of gum diseases (e. g. , gingivitis or periodontitis) and to methods of using such compositions.
NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.